Abstracts (HTML) List of Authors

Bach, P.

Therapeutic drug monitoring in relapse prevention of alcohol dependent patients

Banaschewski, T.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Bergemann, N

Mood stabilizers during pregnancy – significance of therapeutic drug monitoring

Bergemann, N.

The therapeutic reference range for olanzapine revised – how to combine old and new findings

Binder, L.

Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism

Bleich, S.

Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting

Boettcher, M

Drug interactions in patients undergoing opioid maintenance therapy

Böttcher, K.

Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination

Böttcher, M.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

Briegel, W.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting